세계의 지방 조직 유래 줄기세포 시장 보고서(2025년)

Adipose tissue-derived stem cells are multipotent mesenchymal stem cells extracted from adipose (fat) tissue that can differentiate into multiple cell types, including adipocytes, osteoblasts, chondrocytes, and myocytes. These cells are easily obtained through minimally invasive procedures and exhibit strong regenerative, anti-inflammatory, and immunomodulatory characteristics.

The primary components of adipose-tissue-derived stem cells include mesenchymal stem cells (MSCs), adipose-derived stem cells (ADSCs), and adipose-stromal cells (ASCs). Adipose-tissue-derived mesenchymal stem cells (MSCs) are multipotent stromal cells isolated from fat tissue that can develop into various cell types, such as bone, cartilage, and fat cells, and play a key role in tissue repair and regeneration. The various types include autologous stem cells and allogeneic stem cells. Applications include regenerative medicine, tissue engineering, cell therapy, and other uses. The primary end users include biotechnology companies and academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The adipose tissue derived stem cell market research report is one of a series of new reports from The Business Research Company that provides adipose tissue derived stem cell market statistics, including adipose tissue derived stem cell industry global market size, regional shares, competitors with a adipose tissue derived stem cell market share, detailed adipose tissue derived stem cell market segments, market trends and opportunities, and any further data you may need to thrive in the adipose tissue derived stem cell industry. This adipose tissue derived stem cell market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adipose tissue-derived stem cell market size has grown rapidly in recent years. It will grow from $1.07 billion in 2024 to $1.20 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be linked to increasing research activities in regenerative medicine, rising prevalence of chronic and degenerative diseases, growing demand for minimally invasive therapies, expanding applications in cosmetic and reconstructive surgeries, and rising government and private funding for stem cell research.

The adipose tissue-derived stem cell market size is expected to see rapid growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be driven by a continued rise in chronic and degenerative diseases, a growing geriatric population increasing demand for regenerative treatments, a rise in clinical trials and regulatory approvals for adipose-derived therapies, the expansion of biobanks and stem cell storage facilities, and increasing commercialization of stem-cell-based products. Major trends in the forecast period include progress in personalized regenerative therapies, advancements in manufacturing and scale-up for clinical use, innovation in allogeneic adipose-derived product development, integration of automation and closed-system bioreactors, and advancements in regulatory pathways and standardization.

The increasing demand for alternative therapies is expected to contribute significantly to the growth of the adipose tissue-derived stem cell market going forward. Alternative therapies refer to non-conventional treatments used either in place of or alongside standard medical practices to promote healing and overall well-being. The demand for such therapies is rising due to growing consumer awareness of the potential side effects of conventional medicines, prompting more individuals to seek natural and holistic treatment options that support long-term health. Adipose tissue-derived stem cells align with this trend by promoting natural tissue regeneration and healing, offering a minimally invasive and holistic approach to treating various chronic and degenerative conditions. For instance, in December 2023, according to a report published by Complementary Medicines Australia (CMA), an Australia-based industry association, the complementary medicines industry plays a vital role in supporting health and well-being while contributing significantly to the national economy, with annual revenue reaching approximately $6.4 billion in 2023, marking a 7% increase from 2022. Therefore, the growing demand for alternative therapies is expected to drive the expansion of the adipose tissue-derived stem cell market.

Leading companies in the adipose tissue-derived stem cell market are focusing on advancements in stem cell technologies, such as mesenchymal stem cells, to enhance therapeutic efficacy, safety, and clinical outcomes in regenerative medicine applications. Mesenchymal stem cells (MSCs) are multipotent stromal cells capable of differentiating into various cell types, including bone, cartilage, and adipose cells. They play a crucial role in tissue repair, regeneration, and immune modulation, making them valuable for regenerative medicine and therapeutic applications. For instance, in April 2023, Celltex Therapeutics Corporation, a US-based biotechnology company specializing in adipose-derived stem cell banking and therapy, announced advancements in its proprietary cell expansion technology designed to enhance the viability and therapeutic potential of adipose-derived stem cells for clinical applications. This development marked a significant step forward in strengthening the company's position in the regenerative medicine market and demonstrated its commitment to pioneering safe and effective adipose-derived stem cell therapies aimed at improving patient outcomes across a range of chronic and degenerative conditions.

In November 2023, Global Stem Cells Group Inc., a US-based medical company providing adipose tissue-derived stem cells, partnered with StemBio Co., Ltd. Through this partnership, Global Stem Cells Group, Inc. aims to collaborate with StemBio Co. Ltd. to advance research and development in regenerative medicine by integrating innovative stem cell technologies, expanding clinical applications, and enhancing global access to cutting-edge stem cell therapies for improved patient outcomes. StemBio Co. Ltd. is a South Korea-based biotechnology company specializing in stem cell research, culture media development, and biopharmaceutical innovation for regenerative medicine applications.

Major companies operating in the adipose tissue derived stem cell market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Lonza Group AG, STEMCELL Technologies Inc., CYAGEN US INC., TELA Bio Inc., RoosterBio Inc., AdipoSeeds Inc., Celltex Therapeutics Corporation, Yocon Biology Technology Company, iXCells Biotechnologies Inc., LIFELINE CELL TECHNOLOGY LLC, BioRestorative Therapies Inc., Lipogems International S.p.A., Cell Applications Inc., R3 Stem Cell LLC, Stem Cells Care (india) Private Limited, InGeneron Inc., MITAKY High-Tech Corporation

North America was the largest region in the adipose tissue derived stem cell market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in adipose tissue-derived stem cell report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the adipose tissue-derived stem cell market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The adipose tissue-derived stem cell market includes revenues earned by providing services such as stem cell banking services, contract research services, personalized regenerative therapy services, quality assurance and validation services, and biobanking and logistics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adipose Tissue Derived Stem Cell Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adipose tissue derived stem cell market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adipose tissue derived stem cell ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The adipose tissue derived stem cell market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Cell Type: Mesenchymal Stem Cells (MSCS); Adipose-Derived Stem Cells (ADSCS); Adipose-Stromal Cells (ASCS)
• 2) By Type: Autologous Stem Cells; Allogeneic Stem Cells
• 3) By Application: Regenerative Medicine; Tissue Engineering; Cell Therapy; Other Applications
• 4) By End-User: Biotechnology Companies; Academic And Research Institutes
• Subsegments:
• 1) By Mesenchymal Stem Cells: Bone Marrow Derived Mesenchymal Stem Cells; Umbilical Cord Derived Mesenchymal Stem Cells; Placenta Derived Mesenchymal Stem Cells; Dental Pulp Derived Mesenchymal Stem Cells
• 2) By Adipose-Derived Stem Cells: Subcutaneous Adipose Derived Stem Cells; Visceral Adipose Derived Stem Cells; Perivascular Adipose Derived Stem Cells; Brown Adipose Derived Stem Cells
• 3) By Adipose-Stromal Cells: Stromal Vascular Fraction Cells; Preadipocyte Stromal Cells; Endothelial Progenitor Stromal Cells; Pericyte Stromal Cells
• Companies Mentioned: Thermo Fisher Scientific Inc.; Takeda Pharmaceutical Company Limited; Merck KGaA; Lonza Group AG; STEMCELL Technologies Inc.; CYAGEN US INC.; TELA Bio Inc.; RoosterBio Inc.; AdipoSeeds Inc.; Celltex Therapeutics Corporation; Yocon Biology Technology Company; iXCells Biotechnologies Inc.; LIFELINE CELL TECHNOLOGY LLC; BioRestorative Therapies Inc.; Lipogems International S.p.A.; Cell Applications Inc.; R3 Stem Cell LLC; Stem Cells Care (india) Private Limited; InGeneron Inc.; MITAKY High-Tech Corporation
• Countries:

Table of Contents

1. Executive Summary

2. Adipose Tissue Derived Stem Cell Market Characteristics

3. Adipose Tissue Derived Stem Cell Market Trends And Strategies

4. Adipose Tissue Derived Stem Cell Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Adipose Tissue Derived Stem Cell Growth Analysis And Strategic Analysis Framework

• 5.1. Global Adipose Tissue Derived Stem Cell PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Adipose Tissue Derived Stem Cell Market Growth Rate Analysis
• 5.4. Global Adipose Tissue Derived Stem Cell Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Adipose Tissue Derived Stem Cell Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Adipose Tissue Derived Stem Cell Total Addressable Market (TAM)

6. Adipose Tissue Derived Stem Cell Market Segmentation

• 6.1. Global Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mesenchymal Stem Cells (MSCS)
• Adipose-Derived Stem Cells (ADSCS)
• Adipose-Stromal Cells (ASCS)
• 6.2. Global Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autologous Stem Cells
• Allogeneic Stem Cells
• 6.3. Global Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regenerative Medicine
• Tissue Engineering
• Cell Therapy
• Other Applications
• 6.4. Global Adipose Tissue Derived Stem Cell Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biotechnology Companies
• Academic And Research Institutes
• 6.5. Global Adipose Tissue Derived Stem Cell Market, Sub-Segmentation Of Mesenchymal Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bone Marrow Derived Mesenchymal Stem Cells
• Umbilical Cord Derived Mesenchymal Stem Cells
• Placenta Derived Mesenchymal Stem Cells
• Dental Pulp Derived Mesenchymal Stem Cells
• 6.6. Global Adipose Tissue Derived Stem Cell Market, Sub-Segmentation Of Adipose-Derived Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Subcutaneous Adipose Derived Stem Cells
• Visceral Adipose Derived Stem Cells
• Perivascular Adipose Derived Stem Cells
• Brown Adipose Derived Stem Cells
• 6.7. Global Adipose Tissue Derived Stem Cell Market, Sub-Segmentation Of Adipose-Stromal Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stromal Vascular Fraction Cells
• Preadipocyte Stromal Cells
• Endothelial Progenitor Stromal Cells
• Pericyte Stromal Cells

7. Adipose Tissue Derived Stem Cell Market Regional And Country Analysis

• 7.1. Global Adipose Tissue Derived Stem Cell Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Adipose Tissue Derived Stem Cell Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Adipose Tissue Derived Stem Cell Market

• 8.1. Asia-Pacific Adipose Tissue Derived Stem Cell Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Adipose Tissue Derived Stem Cell Market

• 9.1. China Adipose Tissue Derived Stem Cell Market Overview
• 9.2. China Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Adipose Tissue Derived Stem Cell Market

• 10.1. India Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Adipose Tissue Derived Stem Cell Market

• 11.1. Japan Adipose Tissue Derived Stem Cell Market Overview
• 11.2. Japan Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Adipose Tissue Derived Stem Cell Market

• 12.1. Australia Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Adipose Tissue Derived Stem Cell Market

• 13.1. Indonesia Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Adipose Tissue Derived Stem Cell Market

• 14.1. South Korea Adipose Tissue Derived Stem Cell Market Overview
• 14.2. South Korea Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Adipose Tissue Derived Stem Cell Market

• 15.1. Western Europe Adipose Tissue Derived Stem Cell Market Overview
• 15.2. Western Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Adipose Tissue Derived Stem Cell Market

• 16.1. UK Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Adipose Tissue Derived Stem Cell Market

• 17.1. Germany Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Adipose Tissue Derived Stem Cell Market

• 18.1. France Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Adipose Tissue Derived Stem Cell Market

• 19.1. Italy Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Adipose Tissue Derived Stem Cell Market

• 20.1. Spain Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adipose Tissue Derived Stem Cell Market

• 21.1. Eastern Europe Adipose Tissue Derived Stem Cell Market Overview
• 21.2. Eastern Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Adipose Tissue Derived Stem Cell Market

• 22.1. Russia Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Adipose Tissue Derived Stem Cell Market

• 23.1. North America Adipose Tissue Derived Stem Cell Market Overview
• 23.2. North America Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Adipose Tissue Derived Stem Cell Market

• 24.1. USA Adipose Tissue Derived Stem Cell Market Overview
• 24.2. USA Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Adipose Tissue Derived Stem Cell Market

• 25.1. Canada Adipose Tissue Derived Stem Cell Market Overview
• 25.2. Canada Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Adipose Tissue Derived Stem Cell Market

• 26.1. South America Adipose Tissue Derived Stem Cell Market Overview
• 26.2. South America Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Adipose Tissue Derived Stem Cell Market

• 27.1. Brazil Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Adipose Tissue Derived Stem Cell Market

• 28.1. Middle East Adipose Tissue Derived Stem Cell Market Overview
• 28.2. Middle East Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Adipose Tissue Derived Stem Cell Market

• 29.1. Africa Adipose Tissue Derived Stem Cell Market Overview
• 29.2. Africa Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Adipose Tissue Derived Stem Cell Market Competitive Landscape And Company Profiles

• 30.1. Adipose Tissue Derived Stem Cell Market Competitive Landscape
• 30.2. Adipose Tissue Derived Stem Cell Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. STEMCELL Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Adipose Tissue Derived Stem Cell Market Other Major And Innovative Companies

• 31.1. CYAGEN US INC.
• 31.2. TELA Bio Inc.
• 31.3. RoosterBio Inc.
• 31.4. AdipoSeeds Inc.
• 31.5. Celltex Therapeutics Corporation
• 31.6. Yocon Biology Technology Company
• 31.7. iXCells Biotechnologies Inc.
• 31.8. LIFELINE CELL TECHNOLOGY LLC
• 31.9. BioRestorative Therapies Inc.
• 31.10. Lipogems International S.p.A.
• 31.11. Cell Applications Inc.
• 31.12. R3 Stem Cell LLC
• 31.13. Stem Cells Care (india) Private Limited
• 31.14. InGeneron Inc.
• 31.15. MITAKY High-Tech Corporation

32. Global Adipose Tissue Derived Stem Cell Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adipose Tissue Derived Stem Cell Market

34. Recent Developments In The Adipose Tissue Derived Stem Cell Market

35. Adipose Tissue Derived Stem Cell Market High Potential Countries, Segments and Strategies

• 35.1 Adipose Tissue Derived Stem Cell Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Adipose Tissue Derived Stem Cell Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Adipose Tissue Derived Stem Cell Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer